Official Title
Clinical and Psycho-Social Impact on Patients With Digestive Tumors of Treatment and Care Modifications Linked to COVID-19 in France
Brief Summary

To limit Corona virus dissemination on its territory, France applied strict confinement from March 16th to May 11th. Scientific societies recommended treatment modifications and remote consultations that were applied. This study evaluates the clinical impact of these care adaptation on patients under treatment for a digestive tumor. A special focus is made on quality of life and psycho-social impact of treatment modifications on patients diagnosed with metastatic colorectal cancer and metastatic pancreatic cancer.

Completed
Chemeotherapy
Immunotherapy
Treatment Mofidied
Coronavirus
Quality of Life

Other: Psycho-Social Questionnaire

Patients, after enrollmenet in the study, receive a paper questionnaire during the month following COVID19 related confinement and all the material to send it back to the institution. They receive the same questionnaire 3 months later with all the material to send it back to the institution. The intervention is the same for all patients wether their treatment was modified or not.

Eligibility Criteria

Inclusion Criteria:

- Histologically proven digestive tumor

- Ongoing treatment from March,1st and April 30th

Exclusion Criteria:

- Patient refusal for enrollment in the study

- Patient not recognised legally competent

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
France
Locations

MOULIN Valérie
La Rochelle, France

BOURGEOIS Hugues
Le Mans, France

RANDRIAN Violaine
Poitiers, France

Poitiers University Hospital
NCT Number